The Open Source Imaging Consortium is a co-operative effort between academia, industry and philanthropy to enable rapid advances in the fight against Idiopathic Pulmonary Fibrosis (IPF) and other progressive interstitial lung diseases (ILDs).
Radiologists, clinicians and computational scientists from around the world will collaborate on development of digital imaging biomarkers for accurate imaging-based diagnosis, prognosis and prediction of response to therapy.